Speaker in this video:
Dr Sanjit Singh Lamba, Managing Partner, Trillyum Consulting
Topic: Impact of AI in enhancing quality and compliance
Key Takeaways:
[1] AI is not a replacement for pharma’s quality systems. It is a layer of intelligence that unlocks step-change performance.
[2] The future of compliance is predictive, not reactive. AI can identify patterns, flag deviations early, and even recommend CAPAs before issues escalate.
[3] AI is no longer a “nice-to-have.” As regulatory expectations grow and data volumes explode, intelligent systems are becoming essential for quality and compliance.